A subset of TAMs expressing SPP1, also known as osteopontin (OPN), has been identified as markers of poor prognosis and immune checkpoint blockade (ICB) resistance in several types of tumors, including lung adenocarcinoma, hepatocellular carcinoma, and colorectal cancer (92–100). The gene discussed is SPP1; the disease is hepatocellular carcinoma.